Results for "Systemic Symptoms"
Conditions Encyclopedia Entry 1776004864
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1777485186
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of mitochondrial myopathies can vary widely depending on the specific disorder and the individual affected. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. The disorders are typically characterized by progressive muscle weakness, fatigue, and other systemic symptoms. In some cases, mitochondrial myopathies can be associated with other conditions, such as diabetes, seizures, and vision problems. ### History/Background Mitochondrial myopathies were first described in the 1960s, when researchers began to understand the role of mitochondria in energy production. The first cases of mitochondrial myopathies were reported in the 1970s, and since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying these disorders. One of the key milestones in the history of mitochondrial myopathies was the discovery of the first mitochondrial DNA mutation in 1988. This discovery led to a greater understanding of the genetic basis of mitochondrial myopathies and paved the way for the development of genetic testing for these disorders. ### Key Information Mitochondrial myopathies are a diverse group of disorders, and there are over 150 known mitochondrial DNA mutations that can cause these conditions. Some of the most common mitochondrial myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: This disorder is characterized by progressive muscle weakness, seizures, and other systemic symptoms. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: This disorder is characterized by muscle weakness, seizures, and other systemic symptoms. * **Kearns-Sayre Syndrome (KSS)**: This disorder is characterized by progressive muscle weakness, vision problems, and other systemic symptoms. ### Significance Mitochondrial myopathies are significant because they can have a profound impact on the quality of life of affected individuals. These disorders can cause progressive muscle weakness, fatigue, and other systemic symptoms, which can make everyday activities challenging. In some cases, mitochondrial myopathies can be associated with other conditions, such as diabetes, seizures, and vision problems. The significance of mitochondrial myopathies extends beyond the individual affected. These disorders can have a significant impact on families and communities, particularly in cases where the disorder is inherited. Genetic testing and counseling can help families understand the risk of passing on the disorder to future generations. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** 1960s (first described) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, fatigue, and other systemic symptoms **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Systemic Symptoms, MELAS, MERRF, KSS, Mitochondrial DNA Mutations, Genetic Testing, Counseling
Health & MedicineConditions Encyclopedia Entry 1779782464
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the functioning of the mitochondria. Mitochondria are responsible for generating energy for the cell through the process of oxidative phosphorylation. In mitochondrial myopathies, the energy production is impaired, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. These disorders can affect individuals of any age, from infancy to adulthood, and can be inherited in an autosomal dominant, autosomal recessive, or maternal pattern. Mitochondrial myopathies are characterized by a range of clinical features, including muscle weakness, particularly in the proximal muscles (those closest to the trunk of the body), fatigue, exercise intolerance, and other systemic symptoms such as gastrointestinal problems, hearing loss, and visual disturbances. In some cases, individuals with mitochondrial myopathies may experience seizures, ataxia (loss of coordination), and other neurological symptoms. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with a rare disorder characterized by muscle weakness, fatigue, and other systemic symptoms. Over the years, advances in genetic testing and molecular biology have led to a better understanding of the underlying causes of mitochondrial myopathies. In 1988, the first mitochondrial DNA mutation was identified, and since then, numerous other mutations have been discovered, leading to a greater understanding of the genetic basis of these disorders. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA that affect the functioning of the mitochondria. The most common mutations associated with mitochondrial myopathies include: * **MELAS syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes): a disorder characterized by muscle weakness, seizures, and other neurological symptoms. * **MERRF syndrome** (Myoclonus Epilepsy with Ragged-Red Fibers): a disorder characterized by muscle weakness, seizures, and other neurological symptoms. * **KSS syndrome** (Kearns-Sayre Syndrome): a disorder characterized by muscle weakness, hearing loss, and other systemic symptoms. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. These disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these conditions. Furthermore, research into mitochondrial myopathies has led to a greater understanding of the role of mitochondria in human disease and has implications for the treatment of other disorders, such as neurodegenerative diseases. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** 1960s (first reported cases) - **Location:** Global - **Known For:** Impaired energy production in cells leading to muscle weakness, fatigue, and other systemic symptoms. **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Systemic Symptoms, MELAS Syndrome, MERRF Syndrome, KSS Syndrome, Mitochondrial DNA, Nuclear DNA.